Y2X Pathogen Detectors Developed by WashU Team of Professors
September 19, 2021 – Announcement Pathogen Detectors: Y2X Life Sciences and a team of Professors at Washington University, St. Louis (WashU) have developed pathogen detectors designed to identify aerosolized SARS-CoV-2 in people and large indoor spaces.
- The Y2X-DX is a breathalyzer that immediately detects coronavirus in individuals entering workplaces or other semi-public areas.
- The Y2X-AQ is an aerosol detector designed to continuously monitor air quality in large gathering places, such as conference halls, government facilities, military installations and vessels, airports, and schools.
The licensed biosensor technology is a multidisciplinary collaborative effort by researchers from the School of Medicine and McKelvey School of Engineering at Washington University in St. Louis. John Cirrito, PhD, associate professor of neurology led the team of Carla Yuede, PhD, associate professor of psychiatry, and Rajan Chakrabarty, PhD, the Harold D. Jolley Career Development Associate Professor. Professor Chakrabarty also leads the University’s Complex Aerosol Systems Research Laboratory. The team received a grant from the National Institutes of Health for the project through the RADx initiative (Rapid Acceleration of Diagnostics). The core technology for the biosensor is based on research developed by Cirrito’s laboratory that is currently used for Alzheimer’s disease and brain metabolism research.
Learn more about our option agreement with WashU, announcement of pathogen detectors, and latest cutting-edge technologies.